NOVONIX Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	5.93	5.85	8.05	5.4	6.1	3.89
Revenue	5.93	5.85	8.05	5.4	6.1	3.89
Revenue Growth (YoY)	-13.73%	-27.32%	49.03%	-11.42%	56.69%	36.57%
Cost of Revenue	1.41	1.77	2.82	2.64	1.72	0.81
Gross Profit	4.52	4.08	5.24	2.77	4.38	3.08
Selling, General & Admin	49.39	49.08	44.83	50.77	39.86	11.67
Research & Development	4.85	4.85	5.75	4.04	5.1	2.09
Operating Expenses	55.46	58.49	55.32	59.96	49.18	15.03
Operating Income	-50.93	-54.41	-50.08	-57.19	-44.8	-11.94
Interest Expense	-3.48	-3.54	-2.85	-1.83	-1.47	-0.14
Interest & Investment Income	1.37	1.37	1.61	0.04	0.01	0.03
Currency Exchange Gain (Loss)	-0.15	-1.18	1.36	2.72	5.2	-0.06
Other Non Operating Income (Expenses)	2.35	-1.66	3.51	0.54	-2.68	0.58
EBT Excluding Unusual Items	-50.84	-59.42	-46.45	-55.73	-43.75	-11.54
Gain (Loss) on Sale of Investments	-15.31	-15.31	-	-	-8.11	-
Asset Writedown	-	-	-	-	-	-2
Other Unusual Items	-	-	-	-	-	0.1
Pretax Income	-66.15	-74.72	-46.45	-55.73	-51.86	-13.45
Income Tax Expense	0.1	0.1	-0.2	-	-	-
Net Income	-66.25	-74.82	-46.25	-55.73	-51.86	-13.45
Net Income to Common	-66.25	-74.82	-46.25	-55.73	-51.86	-13.45
Shares Outstanding (Basic)	566	497	487	487	464	366
Shares Outstanding (Diluted)	566	497	487	487	464	366
Shares Change (YoY)	15.96%	1.93%	0.18%	4.78%	26.80%	169.49%
EPS (Basic)	-0.12	-0.15	-0.09	-0.11	-0.11	-0.04
EPS (Diluted)	-0.12	-0.15	-0.09	-0.12	-0.11	-0.04
Free Cash Flow	-94.98	-70.32	-55.42	-86.76	-112.99	-25.66
Free Cash Flow Per Share	-0.17	-0.14	-0.11	-0.18	-0.24	-0.07
Gross Margin	76.25%	69.76%	65.02%	51.16%	71.73%	79.18%
Operating Margin	-858.71%	-929.39%	-621.75%	-1058.22%	-734.29%	-306.70%
Profit Margin	-1116.88%	-1278.04%	-574.19%	-1031.13%	-850.01%	-345.34%
Free Cash Flow Margin	-1601.38%	-1201.22%	-688.11%	-1605.40%	-1851.97%	-659.13%
EBITDA	-46.95	-50.46	-45.77	-52.48	-41.02	-10.68
EBITDA Margin	-	-	-	-	-	-274.22%
D&A For EBITDA	3.98	3.95	4.31	4.71	3.78	1.26
EBIT	-50.93	-54.41	-50.08	-57.19	-44.8	-11.94

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q